Catalysts for Fresenius Kabi USA LLC

DILAUDID-HP (HYDROMORPHONE HYDROCHLORIDE) — FDA approval

Fresenius Kabi USA, LLC recall (Cls I)

DALBAVANCIN HYDROCHLORIDE — FDA approval

Fresenius Kabi USA, LLC device recall (Cls II)

DIPRIVAN (PROPOFOL) — FDA approval

Fresenius Kabi USA, LLC device recall (Cls I)

DALBAVANCIN HYDROCHLORIDE — FDA approval

Fresenius Kabi USA, LLC device recall (Cls I)

Fresenius Kabi USA, LLC device recall (Cls II)

CONEXXENCE (DENOSUMAB-BNHT) — FDA approval

GLYCOPYRROLATE — FDA approval

DALBAVANCIN HYDROCHLORIDE — FDA approval

STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approval

IFOSFAMIDE — FDA approval

CAFFEINE CITRATE — FDA approval

Fresenius Kabi USA, LLC device recall (Cls II)

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

Denver Solutions, LLC DBA Leiters Health recall (Cls II)

Denver Solutions, LLC DBA Leiters Health recall (Cls II)

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approval

CONEXXENCE (DENOSUMAB-BNHT) — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

TYENNE (TOCILIZUMAB-AAZG) — FDA approval

OTULFI (USTEKINUMAB-AAUZ) — FDA approval